Pharmaceutical Technology on MSN10d
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara to treat large ...
Monthly Prescribing Reference7y
Glyburide/metformin
Glyburide, metformin HCl; 2.5mg/500mg, 5mg/500mg; tabs. Take with meals. Individualize. Not controlled on diet/exercise (use individual components): initially glyburide 1.25mg and metformin 250mg ...
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
Medscape28d
Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift?
Data Synthesis: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metformin and rosiglitazone cross readily. Animal studies have found ...